Regulatory Subcommittee

The Regulatory Subcommittee assists the Policy and Advocacy Committee in the articulation, development and dissemination of SITC’s recommended U.S. Food and Drug Administration (FDA) and appropriations and congressional report language. The subcommittee also reviews and analyzes immunotherapy and oncology policy issues related to clinical trial design, management of toxicity and adverse events reporting and other activities under the FDA Oncology Center of Excellence.


Emily Hopewell, PhD
Indiana University

Current Members
8 Members